Navigation Links
As personalized, genomic medicine takes off, four developing countries show the way for others
Date:9/19/2008

Developing countries that want the benefits of cutting-edge health care possibilities based on the genetic variation of individual citizens and sub-populations need to foster the new science at home, says a major new Canadian study published today by Nature Publishing Group.

In a special six-paper supplement of the journal Nature Reviews Genetics (NRG), researchers from the McLaughlin-Rotman Centre for Global Health (MRC), Toronto, say four countries with emerging economies -- Mexico, India, Thailand and South Africa -- are showing the way for others in similar economic circumstances.

The study details how those four countries are actively establishing domestic capacity in genomic medicine efforts that will improve national health, slash medical costs through better resource allocation, and bolster their economies.

The two-year study was undertaken by Dr. Batrice Sguin, Billie-Jo Hardy, Dr. Peter A. Singer and Prof. Abdallah S. Daar of the MRC, part of Toronto's University Health Network and the University of Toronto.

Says project leader Dr. Sguin, who is also assistant professor at the Leslie Dan Faculty of Pharmacy: "Developing countries have much to gain from genomic medicine and can least afford to waste precious resources on ineffective therapies and diagnostics."

"Benefits of this emerging science cannot be an exclusive luxury reserved for wealthier industrialized countries," she says. "Instead, it must be universally advanced by developed and developing countries alike to prevent an increased widening of already huge difference in global health care quality."

Says Prof. Daar, the project's principal investigator, a professor of public health sciences at the University of Toronto and co-director of the MRC's Program on Life Sciences, Ethics and Policy: "The world has reached an historic moment on the path to genomic medicine the point where theory is about to be translated into practic
'/>"/>

Contact: Terry Collins
terrycollins@rogers.com
416-538-8712
Program on Life Sciences, Ethics and Policy,McLaughlin-Rotman Centre for Global Health
Source:Eurekalert  

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
2. Brewing better beer: Scientists determine the genomic origins of lager yeasts
3. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
4. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
5. Rosetta Genomics Reports Second Quarter 2008 Financial Results
6. DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature
7. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
8. Transgenomic Reports Second Quarter 2008 Results
9. Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress
10. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
11. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
As personalized, genomic medicine takes off, four developing countries show the way for others
As personalized, genomic medicine takes off, four developing countries show the way for others
(Date:11/25/2009)...--ResearchTrianglePark-basedCnanozInc.unveiledthef...tionsystemNanoPure(TM)developedfromcarbonnanotubes...isterViswarupandotherleadersinHyderabad,Indiatoday...gy(IIT)Kanpur,confirmedthatthemajorityofthedrinkin...melyhazardoustohumanhealth. ,, Thetechnologydev...
(Date:11/25/2009).../PRNewswire/--Formanybusinesses,2009hasbeenapainfu...testgrowingnetworkofexpertphysiciansspecializingex...s has grownthenumberof physiciansinitsnetwork ...gresstoaddmorephysician-ownedcenters,includingonei...r ,BodyLogicMDhasopened13newbioidenticalhormonespe...
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...lMarketAnalysisandForecaststo2013 ,, http://w...ket-Analysis-and-Forecasts-to-2013.html ,, Bra..., Summary ,, Thereportprovidesdetailedanalysi...ilbioethanolmarketinparticular.Italsohelpsinanalyz...
(Date:11/24/2009)...tCall/--IES(Nasdaq: IESC ),aleadingnationalprovide...rthecommercial,industrialandresidentialmarkets,ann...ardedacontractfromManhattanTorconJVtoinstalltheele...acementfacilityattheU.S.ArmyMedicalResearchInstitu...derick,Md. ,, ThenewUSAMRIIDreplacementfacility...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...NCOUVER, Jan. 9 /PRNewswire/ - Sirius Genomics, a ...y that it has signed a collaborative agreement wit...) Group. The agreement focuses on the continued de...r responsiveness to recombinant activated Protein ...rk Xigris(R)). , "The UKCCG group is conducting a ...
... DUBLIN, Ireland, January 9 Azur Pharma Limited ...he exclusive U.S. marketing rights,for Niravam(R) ...a(R),(carbidopa-levodopa orally disintegrating tab... tablets) and Fluxid(TM) (famotidine orally,disint...ial terms were not,disclosed. , Niravam, Parco...
... LOS ALTOS, Calif., Jan. 8 InteKrin Therapeutics...lobal Healthcare Conference at,9:00 a.m. Pacific T...e Westin,St. Francis in San Francisco, California....nfear will present at the conference. , About ...in Therapeutics is a privately-held clinical stage...
Other Biology Technology:Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group 2Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB 2InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13 2
(Date:11/25/2009)...Bacteria don,t have easy lives. In addition to mam...have natural enemies called bacteriophages, viruse...ays. , Still, bacteria and another class of mic...treme environments such as deep-sea volcanic vents...y have a built-in defense system that helps protec...
(Date:11/25/2009)...e University assistant professors recently receive...F) to continue research beneficial to understandin.... , Christopher Blackwood, assistant professor i...ed grants to support two separate research project...r Decomposer Communities and Functions from the Le...
(Date:11/24/2009)...ve crystallised a protein that may help gut bacter... could be used by probiotic producers to identify ...eople. , "Probiotics need to interact with cells ... they attach to surfaces in the gut they are more ...activity," says Dr Nathalie Juge from the Institut...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2WorldatWork Honors Helen Darling NBGH President with Prestigious Keystone Award 48065 1WorldatWork Honors Helen Darling NBGH President with Prestigious Keystone Award 48065 2Marbles 3A The Brain Store Opens New Location in Chicago Introduces World 26apos 3Bs First Bike that Trains Body and Brain 48063 1Marbles 3A The Brain Store Opens New Location in Chicago Introduces World 26apos 3Bs First Bike that Trains Body and Brain 48063 2Marbles 3A The Brain Store Opens New Location in Chicago Introduces World 26apos 3Bs First Bike that Trains Body and Brain 48063 3Spains Regional Extremadura Government Launches Electronic Prescription System With IBM 48061 1Spains Regional Extremadura Government Launches Electronic Prescription System With IBM 48061 2
...ple continue to suffer from life-altering, chronic...ed" , The definitive answer -- and an effective tr... analgesic drugs, such as aspirin and morphine der...estern University researcher has found a key sourc...e that essentially gets stuck in the prefrontal co...
...fessor Emad Tajkhorshid and graduate student James...he U. of I.,s National Institutes of Health Resour...to painstakingly model a critical part of a mechan...dit: Photo by L. Brian Stauffer Using X-ray data ... software, researchers at the University of Illino...
...ave joined the battle to save Australia’s iconic T...evastating devil populations. , Researchers from C...lth Laboratory (AAHL), Textiles and Fibre Technolo...t down the cause of Devil Facial Tumour Disease (D...ted animals. , DFTD is infectious and is thoug...
Other Biology News:Old memory traces in brain may trigger chronic pain 2Old memory traces in brain may trigger chronic pain 3Simulations unravel outer membrane transport mechanism 2Simulations unravel outer membrane transport mechanism 3Simulations unravel outer membrane transport mechanism 4CSIRO scientists join fight to save 'Tassie devil' 2
Goat Anti-HSPC150 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human Macrophage-stimulating protein receptor Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Rat Anti-Mouse Reticular Fibroblast (pan) Monoclonal Antibody, Unconjugated, Clone ER-TR7 from CEDARLANE Laboratories Limited
Mouse Anti-HSV1, HSV2 ICP5 Major Capsid Protein Monoclonal Antibody, Unconjugated, Clone 3B6 from Abcam
Biology Products: